Biogen Inc. financial data

Symbol
BIIB on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
225 Binney Street, Cambridge, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Former names
BIOGEN IDEC INC. (to 3/20/2015), BIOGEN IDEC INC (to 4/25/2007), IDEC PHARMACEUTICALS CORP / DE (to 11/12/2003), IDEC PHARMACEUTICALS CORP / CA (to 2/14/1997)
Latest financial report
10-Q - Q2 2024 - Aug 1, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 197 % -33.5%
Quick Ratio 71.2 % +78.9%
Debt-to-equity 82.1 % -17.1%
Return On Equity 7.68 % -60.8%
Return On Assets 4.27 % -60.2%
Operating Margin 22.9 % -22.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 146M shares +0.58%
Common Stock, Shares, Outstanding 145M shares +0.63%
Entity Public Float 41.2B USD +40.1%
Common Stock, Value, Issued 100K USD 0%
Weighted Average Number of Shares Outstanding, Basic 146M shares +0.62%
Weighted Average Number of Shares Outstanding, Diluted 146M shares +0.28%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 9.67B USD -3%
Costs and Expenses 8.36B USD +22%
Operating Income (Loss) 2.48B USD -33.1%
Nonoperating Income (Expense) -852M USD -867%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 699M USD -1.33%
Income Tax Expense (Benefit) 156M USD -65.7%
Net Income (Loss) Attributable to Parent 1.16B USD -56.5%
Earnings Per Share, Basic 7.96 USD/shares -56.8%
Earnings Per Share, Diluted 7.93 USD/shares -56.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current 1.66B USD -2.4%
Inventory, Net 2.51B USD +87.9%
Other Assets, Current 615M USD -31.3%
Assets, Current 7.11B USD -31.9%
Deferred Income Tax Assets, Net 915M USD -24.3%
Property, Plant and Equipment, Net 3.25B USD -1.75%
Operating Lease, Right-of-Use Asset 389M USD +6.25%
Intangible Assets, Net (Excluding Goodwill) 8.23B USD +363%
Goodwill 6.23B USD +8.23%
Other Assets, Noncurrent 682M USD -38.3%
Assets 26.8B USD +6.55%
Accounts Payable, Current 355M USD -20.4%
Employee-related Liabilities, Current 228M USD -9.87%
Liabilities, Current 3.11B USD -2.46%
Accrued Income Taxes, Noncurrent 192M USD -50%
Deferred Income Tax Liabilities, Net 591M USD +310%
Operating Lease, Liability, Noncurrent 368M USD +20.7%
Other Liabilities, Noncurrent 557M USD -28.3%
Liabilities 10.9B USD +2.05%
Accumulated Other Comprehensive Income (Loss), Net of Tax -146M USD +15.5%
Retained Earnings (Accumulated Deficit) 18.6B USD +6.64%
Stockholders' Equity Attributable to Parent 14.8B USD +10.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 15.9B USD +9.88%
Liabilities and Equity 26.8B USD +6.55%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 553M USD +21.5%
Net Cash Provided by (Used in) Financing Activities -440M USD -913%
Net Cash Provided by (Used in) Investing Activities -66M USD +93.1%
Common Stock, Shares Authorized 1B shares 0%
Common Stock, Shares, Issued 169M shares +0.48%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.91B USD -27.1%
Deferred Tax Assets, Valuation Allowance 1.28B USD -36.2%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Operating Lease, Liability 490M USD +14%
Depreciation 269M USD +5.21%
Payments to Acquire Property, Plant, and Equipment 45.9M USD -31.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 1.19B USD -54.4%
Lessee, Operating Lease, Liability, to be Paid 592M USD +25.8%
Property, Plant and Equipment, Gross 5.71B USD +4.54%
Operating Lease, Liability, Current 90.3M USD -7.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 96.1M USD -10.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 106M USD -4.32%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure +27%
Deferred Income Tax Expense (Benefit) 39.9M USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 101M USD +153%
Lessee, Operating Lease, Liability, to be Paid, Year Three 83.5M USD +3.73%
Deferred Tax Assets, Operating Loss Carryforwards 1.7B USD -7.88%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 8M shares 0%
Unrecognized Tax Benefits 173M USD -71.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 86.1M USD +31.1%
Additional Paid in Capital 408M USD +139%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 148M USD +31.3%
Deferred Tax Assets, Net of Valuation Allowance 2.93B USD +13.3%
Share-based Payment Arrangement, Expense -270M USD +6.14%
Interest Expense 266M USD +17.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares